United Therapeutics (UTHR) Non Operating Income (2016 - 2025)
Historic Non Operating Income for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $49.5 million.
- United Therapeutics' Non Operating Income rose 879.12% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.9 million, marking a year-over-year increase of 908.52%. This contributed to the annual value of $162.0 million for FY2024, which is 8120.81% up from last year.
- Per United Therapeutics' latest filing, its Non Operating Income stood at $49.5 million for Q3 2025, which was up 879.12% from $43.9 million recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Non Operating Income ranged from a high of $97.3 million in Q1 2021 and a low of -$51.8 million during Q2 2022
- In the last 5 years, United Therapeutics' Non Operating Income had a median value of $24.8 million in 2023 and averaged $19.4 million.
- Within the past 5 years, the most significant YoY rise in United Therapeutics' Non Operating Income was 101839.08% (2021), while the steepest drop was 105714.29% (2021).
- Quarter analysis of 5 years shows United Therapeutics' Non Operating Income stood at -$28.8 million in 2021, then skyrocketed by 81.6% to -$5.3 million in 2022, then surged by 766.04% to $35.3 million in 2023, then grew by 9.92% to $38.8 million in 2024, then rose by 27.58% to $49.5 million in 2025.
- Its last three reported values are $49.5 million in Q3 2025, $43.9 million for Q2 2025, and $40.7 million during Q1 2025.